192 related articles for article (PubMed ID: 26247473)
21. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
Marini F; Giusti F; Tonelli F; Brandi ML
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
[TBL] [Abstract][Full Text] [Related]
22. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
[TBL] [Abstract][Full Text] [Related]
23. The future: medical advances in MEN1 therapeutic approaches and management strategies.
van Leeuwaarde RS; de Laat JM; Pieterman CRC; Dreijerink K; Vriens MR; Valk GD
Endocr Relat Cancer; 2017 Oct; 24(10):T179-T193. PubMed ID: 28768698
[TBL] [Abstract][Full Text] [Related]
24. Expression of p27
Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
Chiloiro S; Lanza F; Bianchi A; Schinzari G; Brizi MG; Giampietro A; Rufini V; Inzani F; Giordano A; Rindi G; Pontecorvi A; De Marinis L
Endocrine; 2018 May; 60(2):362-367. PubMed ID: 28567607
[TBL] [Abstract][Full Text] [Related]
26. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
[TBL] [Abstract][Full Text] [Related]
27. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
Ramamoorthy B; Nilubol N
Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
[TBL] [Abstract][Full Text] [Related]
28. [Clinical genetics of neuroendocrine tumors].
Karges W; Adler G
Med Klin (Munich); 2003 Dec; 98(12):712-6. PubMed ID: 14685672
[TBL] [Abstract][Full Text] [Related]
29. The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group.
van den Broek MFM; de Laat JM; van Leeuwaarde RS; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Kerstens MN; Bisschop PH; Havekes B; Hackeng WM; Brosens LAA; Vriens MR; Buikhuisen WA; Valk GD
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1014-e1027. PubMed ID: 33135721
[TBL] [Abstract][Full Text] [Related]
30. [Various neuroendocrine tumors in a family with multiple endocrine neoplasia type 1].
Sepp K; Valkusz Z
Orv Hetil; 2013 Dec; 154(51):2037-42. PubMed ID: 24334135
[TBL] [Abstract][Full Text] [Related]
31. Multiple endocrine neoplasia type 1 (MEN1).
Carroll RW
Asia Pac J Clin Oncol; 2013 Dec; 9(4):297-309. PubMed ID: 23279763
[TBL] [Abstract][Full Text] [Related]
32. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.
Emmert-Buck MR; Lubensky IA; Dong Q; Manickam P; Guru SC; Kester MB; Olufemi SE; Agarwal S; Burns AL; Spiegel AM; Collins FS; Marx SJ; Zhuang Z; Liotta LA; Chandrasekharappa SC; Debelenko LV
Cancer Res; 1997 May; 57(10):1855-8. PubMed ID: 9157974
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan.
Sakurai A; Yamazaki M; Suzuki S; Fukushima T; Imai T; Kikumori T; Okamoto T; Horiuchi K; Uchino S; Kosugi S; Yamada M; Komoto I; Hanazaki K; Itoh M; Kondo T; Mihara M; Imamura M
Endocr J; 2012; 59(10):859-66. PubMed ID: 22785103
[TBL] [Abstract][Full Text] [Related]
34. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
[TBL] [Abstract][Full Text] [Related]
35. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
Anlauf M; Schlenger R; Perren A; Bauersfeld J; Koch CA; Dralle H; Raffel A; Knoefel WT; Weihe E; Ruszniewski P; Couvelard A; Komminoth P; Heitz PU; Klöppel G
Am J Surg Pathol; 2006 May; 30(5):560-74. PubMed ID: 16699310
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis.
Ye L; Wang W; Ospina NS; Jiang L; Christakis I; Lu J; Zhou Y; Zhu W; Cao Y; Wang S; Perrier ND; Young WF; Ning G; Wang W
Clin Endocrinol (Oxf); 2017 Dec; 87(6):706-716. PubMed ID: 28940393
[TBL] [Abstract][Full Text] [Related]
37. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
[TBL] [Abstract][Full Text] [Related]
38. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
